These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1976785)

  • 1. Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation.
    Beart PM; Lodge D
    J Pharm Pharmacol; 1990 May; 42(5):354-5. PubMed ID: 1976785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
    McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
    Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced NMDA receptor-ion channel function in the vitamin B-6 restricted neonatal rat brain.
    Guilarte TR
    Neurosci Lett; 1991 Jan; 121(1-2):207-10. PubMed ID: 1708479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical and electrophysiological studies on FR115427, a novel non-competitive NMDA receptor antagonist.
    Hodgkiss JP; Sherriffs HJ; Cottrell DA; Shirakawa K; Kelly JS; Kuno A; Ohkubo M; Butcher SP; Olverman HJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):219-27. PubMed ID: 7902282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CCK release in cerebral cortex by N-methyl-D-aspartate receptors: sensitivity to APV, MK-801, kynurenate, magnesium and zinc ions.
    Bandopadhyay R; de Belleroche J
    Neuropeptides; 1991 Mar; 18(3):159-63. PubMed ID: 1676831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex.
    Harrison NL; Simmonds MA
    Br J Pharmacol; 1985 Feb; 84(2):381-91. PubMed ID: 2858237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of NMDA receptor activation on quisqualate-stimulated phosphatidylinositol turnover in the human cerebral cortex.
    Morari M; Calo G; Antonelli T; Gaist G; Acciarri N; Fabrizi A; Bianchi C; Beani L
    Brain Res; 1991 Jul; 553(1):14-7. PubMed ID: 1834301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies.
    Kiss B; Cai NS; Erdö SL
    Eur J Pharmacol; 1991 Dec; 209(1-2):109-12. PubMed ID: 1687679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.
    Ebert B; Mikkelsen S; Thorkildsen C; Borgbjerg FM
    Eur J Pharmacol; 1997 Aug; 333(1):99-104. PubMed ID: 9311667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
    Fink K; Schultheiss R; Göthert M
    Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex.
    Slater P; McConnell SE; D'Souza SW; Barson AJ
    Br J Pharmacol; 1993 Apr; 108(4):1143-9. PubMed ID: 8097954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studies.
    Graham D; Darles G; Langer SZ
    Eur J Pharmacol; 1992 Aug; 226(4):373-6. PubMed ID: 1356814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex.
    Clow DW; Lee SJ; Hammer RP
    Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex.
    Harada H; Kelly PJ; Cole DJ; Drummond JC; Patel PM
    Anesth Analg; 1999 Dec; 89(6):1442-7. PubMed ID: 10589624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate-induced increases in intracellular Ca2+ in cultured frog tectal cells mediated by direct activation of NMDA receptor channels.
    Cline HT; Tsien RW
    Neuron; 1991 Feb; 6(2):259-67. PubMed ID: 1704244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibenzocycloalkenimine (MK-801) stimulates phosphoinositide hydrolysis in rat cerebral cortical slices).
    Ormandy GC; Li X; Jope RS
    Neuropharmacology; 1990 Aug; 29(8):779-82. PubMed ID: 2177162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice.
    Sharma AC; Thorat SN; Nayar U; Kulkarni SK
    Indian J Physiol Pharmacol; 1991 Apr; 35(2):111-6. PubMed ID: 1838740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate and glycine decrease the affinity of [3H]MK-801 binding in the presence of Mg2+.
    von Euler G; Liu Y
    Eur J Pharmacol; 1993 May; 245(3):233-9. PubMed ID: 7687560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
    Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
    Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.